Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 478389.ª Legislatura (2025)

Qué cambió entre versiones

31 párrafos cambiaron+109 palabras agregadas−73 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

By: VanDeaver (Senate Sponsor - Hancock)

H.B. No. 4783

(In the Senate - Received from the House May 6, 2025;

May 7, 2025, read first time and referred to Committee on Health &

Human Services; May 19, 2025, reported adversely, with favorable

Committee Substitute by the following vote: Yeas 8, Nays 0;

May 19, 2025, sent to printer.)

Click here to see the committee vote

COMMITTEE SUBSTITUTE FOR H.B. No. 4783

By: Perry

A BILL TO BE ENTITLED

AN ACT

43 párrafos sin cambios

relating to a report on governmental opioid antagonist programs to

reverse and prevent opioid overdoses.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Subchapter B, Chapter 461A, Health and Safety

Code, is amended by adding Section 461A.060 to read as follows:

Sec. 461A.060. BIENNIAL REPORT ON OPIOID ANTAGONIST

PROGRAMS FOR OPIOID OVERDOSE REVERSAL AND PREVENTION. (a) In this

section, "opioid antagonist" has the meaning assigned by Section

483.101.

(b) Not later than October 1 of each even-numbered year, the

commission shall:

(1) prepare a report evaluating the distribution of

opioid antagonists in this state to reverse and prevent opioid

overdoses; and

(2) submit the report to the governor, the lieutenant

governor, and the speaker of the house of representatives.

(c) The report described by Subsection (b) must:

(1) include a needs assessment for the opioid

antagonist programs established by state agencies and institutions

of higher education;

(2) establish a statewide saturation goal for opioid

antagonists and include:

(A) a description of the data sources and

methodology used to estimate insufficiencies in the current supply

of opioid antagonists; and

(B) a communications plan to address opioid

overdoses in areas of this state at higher risk for increased

numbers of overdoses;

(3) include a description of all state and federal

money appropriated to governmental opioid antagonist programs;

(4) establish opioid antagonist distribution

strategies for this state;

(5) list and describe all available state and

federally funded purchase and distribution programs for opioid

antagonists; and

(6) recommend improvements for addressing opioid

overdoses among high-risk populations, including school-aged

children, pregnant and postpartum women, and individuals residing

in rural areas of this state.

(d) In preparing the report under this section, the

commission shall coordinate and consult with each state agency and

institution of higher education that receives funding or other

resources for the distribution of opioid antagonists.

SECTION 2. This Act takes effect September 1, 2025.

* * * * *

______________________________

______________________________

President of the Senate

Speaker of the House

I certify that H.B. No. 4783 was passed by the House on May 6,

2025, by the following vote: Yeas 137, Nays 10, 1 present, not

voting; and that the House concurred in Senate amendments to H.B.

No. 4783 on May 23, 2025, by the following vote: Yeas 112, Nays 24,

1 present, not voting.

______________________________

Chief Clerk of the House

I certify that H.B. No. 4783 was passed by the Senate, with

amendments, on May 20, 2025, by the following vote: Yeas 30, Nays

1.

______________________________

Secretary of the Senate

APPROVED: __________________

Date

__________________

Governor

Volver al texto completo